Sign inGet started

Leider Harry L.

Insider CIK 1888273 · OCEL Chief Executive Officer, Director · GLS Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OCEL Organicell Regenerative Me S Sale2023-12-192023-12-205,248$1.32 $6.9K0SEC↗
OCEL Organicell Regenerative Me P Buy2023-06-292023-12-21500,000$0.01 $5.0K1,049,450SEC↗
OCEL Organicell Regenerative Me P Buy2023-06-292023-06-30500,000$0.01 $5.0K1,049,450SEC↗
OCEL Organicell Regenerative Me P Buy2023-06-282023-12-21549,450$0.01 $5.5K549,450SEC↗
OCEL Organicell Regenerative Me P Buy2023-06-282023-06-30549,450$0.10 $54.9K549,450SEC↗
GLS GELESIS HOLDINGS, INC. A Award deriv2022-05-062022-05-09269,660— $0269,660SEC↗
GLS GELESIS HOLDINGS, INC. A Award2022-05-062022-05-0910,164— $010,164SEC↗
GLS GELESIS HOLDINGS, INC. A Award2022-05-062022-05-09269,660— $0314,090SEC↗
GLS GELESIS HOLDINGS, INC. A Award2022-05-062022-05-0934,266— $044,430SEC↗